Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.4 LAccepted-AOC 1521 B 10 WAZIR NAGAR BHISHM PITAMAH MARG KOTLA MUBARAKPUR NEW DELHI 110003 | NEW DELHI | NEW DELHI | DELHI | 110003 | ₹1.4 L | L1 | Accepted-AOC Bid found in order as per bid submitted by firm |
| Sl No | Description | Qty | Unit | Genex Life Sciences Pvt ltd |
|---|---|---|---|---|
| 1.00Procurement of Consumables/Reagents Make M/s Merck KGaA, Germany | ||||
| 1.01 | Trypsin EDTA Solution (T3924-100ml) | 5 | Nos | 10,989 ₹12,967.02 Lowest |
| 1.02 | Pirfenidone (P2116-50mg) | 1 | Nos | 54,601.3 ₹64,429.53 Lowest |
| 1.03 | Tetraethyl orthosilicate (333859-100ml) | 1 | Nos | 19,181.9 ₹22,634.64 Lowest |
| 1.04 | DNase I (AMPD1-1KT) | 2 | Nos | 31,146.6 ₹36,752.99 Lowest |
Tender Value
₹1.4 L
Closing Date
22 Sept 2025, 1:00 pmClosed
Deputy Registrar
3rd Floor Administrative Block MS Building VPCI University of Delhi DU
Procurement of Consumables Reagents Make Ms Merck KGaA Germany
2025_DU_875691_1
VPCI/PUR/OT/GEN/25-26/10-9/35
Open Tender
Consumables (Hospital / Lab)
Supply
60 days
VPCI, DU
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
11 May 2026
2 Sept 2025
23 Sept 2025
2 Sept 2025
22 Sept 2025
2 Sept 2025
Procurement of Consumables/Reagents Make M/s Merck KGaA, Germany
Trypsin EDTA Solution (T3924-100ml)
Pirfenidone (P2116-50mg)
Tetraethyl orthosilicate (333859-100ml)
DNase I (AMPD1-1KT)
stage.html
html • 0.03 MB
tech_eval.pdf
fin_eval.pdf
aoc.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.12 MB
TD35.pdf
Tender Documents • 0.92 MB
BOQ_920516.xls
BOQ • 0.33 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].